These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 7818556)
21. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Boyer SN; Wazer DE; Band V Cancer Res; 1996 Oct; 56(20):4620-4. PubMed ID: 8840974 [TBL] [Abstract][Full Text] [Related]
22. A peptide binding motif for HLA-DQA1*0102/DQB1*0602, the class II MHC molecule associated with dominant protection in insulin-dependent diabetes mellitus. Ettinger RA; Kwok WW J Immunol; 1998 Mar; 160(5):2365-73. PubMed ID: 9498778 [TBL] [Abstract][Full Text] [Related]
23. Specific recognition of four-way DNA junctions by the C-terminal zinc-binding domain of HPV oncoprotein E6. Ristriani T; Nominé Y; Masson M; Weiss E; Travé G J Mol Biol; 2001 Jan; 305(4):729-39. PubMed ID: 11162088 [TBL] [Abstract][Full Text] [Related]
24. Analysis of relative binding affinity of E7-pRB of human papillomavirus 16 clinical variants using the yeast two-hybrid system. Choo KB; Wang TS; Huang CJ J Med Virol; 2000 Jul; 61(3):298-302. PubMed ID: 10861636 [TBL] [Abstract][Full Text] [Related]
25. Exogenous peptide and protein expression levels using retroviral vectors in human cells. Sandrock TM; Risley B; Richards BT; Poritz MA; Austin HA; Yoo S; Kim MK; Roth B; Repetny K; Hsu F; Stump M; Teng DH; Kamb A Mol Ther; 2001 Nov; 4(5):398-406. PubMed ID: 11708876 [TBL] [Abstract][Full Text] [Related]
26. Surface plasmon resonance imaging-based protein arrays for high-throughput screening of protein-protein interaction inhibitors. Jung SO; Ro HS; Kho BH; Shin YB; Kim MG; Chung BH Proteomics; 2005 Nov; 5(17):4427-31. PubMed ID: 16196090 [TBL] [Abstract][Full Text] [Related]
27. Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release. Rubin SM; Gall AL; Zheng N; Pavletich NP Cell; 2005 Dec; 123(6):1093-106. PubMed ID: 16360038 [TBL] [Abstract][Full Text] [Related]
28. Differential regulation of the pocket domains of the retinoblastoma family proteins by the HPV16 E7 oncoprotein. Berezutskaya E; Yu B; Morozov A; Raychaudhuri P; Bagchi S Cell Growth Differ; 1997 Dec; 8(12):1277-86. PubMed ID: 9419416 [TBL] [Abstract][Full Text] [Related]
29. A cyclin D1/cyclin-dependent kinase 4 binding site within the C domain of the retinoblastoma protein. Pan W; Cox S; Hoess RH; Grafström RH Cancer Res; 2001 Apr; 61(7):2885-91. PubMed ID: 11306463 [TBL] [Abstract][Full Text] [Related]
30. Highly specific, cross-reactive sequences recognized by an anti-HBsAg antibody identified from a positional scanning synthetic combinatorial library. Appel JR; Muller S; Benkirane N; Houghten RA; Pinilla C Pept Res; 1996; 9(4):174-82. PubMed ID: 8914164 [TBL] [Abstract][Full Text] [Related]
31. Crystal structure of the E2 DNA-binding domain from human papillomavirus type 16: implications for its DNA binding-site selection mechanism. Hegde RS; Androphy EJ J Mol Biol; 1998 Dec; 284(5):1479-89. PubMed ID: 9878365 [TBL] [Abstract][Full Text] [Related]
32. The binding domain structure of retinoblastoma-binding proteins. Figge J; Breese K; Vajda S; Zhu QL; Eisele L; Andersen TT; MacColl R; Friedrich T; Smith TF Protein Sci; 1993 Feb; 2(2):155-64. PubMed ID: 8382993 [TBL] [Abstract][Full Text] [Related]
33. Proposed interaction between insulin and retinoblastoma protein. Radulescu RT; Wendtner CM J Mol Recognit; 1992 Dec; 5(4):132-7. PubMed ID: 1339481 [TBL] [Abstract][Full Text] [Related]
34. Structural principles in cell-cycle control: beyond the CDKs. Endicott JA; Noble ME Structure; 1998 May; 6(5):535-41. PubMed ID: 9634691 [TBL] [Abstract][Full Text] [Related]
35. Dimerization of CtIP may stabilize in vivo interactions with the Retinoblastoma-pocket domain. Stokes PH; Thompson LS; Marianayagam NJ; Matthews JM Biochem Biophys Res Commun; 2007 Mar; 354(1):197-202. PubMed ID: 17214969 [TBL] [Abstract][Full Text] [Related]
36. Purification and characterization of a functionally homogeneous 60-kDa species of the retinoblastoma gene product. Edwards GM; Huber HE; DeFeo-Jones D; Vuocolo G; Goodhart PJ; Maigetter RZ; Sanyal G; Oliff A; Heimbrook DC J Biol Chem; 1992 Apr; 267(12):7971-4. PubMed ID: 1569054 [TBL] [Abstract][Full Text] [Related]
37. NMR assignment of a PDZ domain in complex with a HPV51 E6 derived N-terminally pyroglutamic acid modified peptide. Mischo A; Ohlenschläger O; Ramachandran R; Görlach M Biomol NMR Assign; 2013 Apr; 7(1):47-9. PubMed ID: 22392342 [TBL] [Abstract][Full Text] [Related]
38. High-mobility group boxes mediate cell proliferation and radiosensitivity via retinoblastoma-interaction-dependent and -independent mechanisms. Wang LL; Meng QH; Jiao Y; Xu JY; Ge CM; Zhou JY; Rosen EM; Wang HC; Fan SJ Cancer Biother Radiopharm; 2012 Jun; 27(5):329-35. PubMed ID: 22655796 [TBL] [Abstract][Full Text] [Related]
39. RB restricts DNA damage-initiated tumorigenesis through an LXCXE-dependent mechanism of transcriptional control. Bourgo RJ; Thangavel C; Ertel A; Bergseid J; McClendon AK; Wilkens L; Witkiewicz AK; Wang JY; Knudsen ES Mol Cell; 2011 Aug; 43(4):663-72. PubMed ID: 21855804 [TBL] [Abstract][Full Text] [Related]